Next, through analyzing the Cancer Genome Atlas (TCGA) dataset, we found that increased expression of ACYP2 was clearly associated with poor survival in low-grade glioma (LGG) patients (HR =0.23 with log-rank P < 0.0001; Fig. 1d), but not in glioblastoma (GBM) patients (data not shown). The gene discussed is ACYP2; the disease is glioblastoma.